TrialInvestigational new drugs2008

O-Mel-Inib: a Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose imatinib mesylate in metastatic uveal melanoma.

Nicolas Penel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.